About CinRx Pharma
CinRx Pharma is a company based in Cincinnati (United States) founded in 2015. CinRx Pharma has raised $83 million across 2 funding rounds. CinRx Pharma operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Cincinnati, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$83 M (USD)
in 2 rounds
-
Latest Funding Round
$73 M (USD), Series B
May 30, 2024
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of CinRx Pharma
Unlock access to complete
Unlock access to complete
Leadership Team
7 people
Board Team
3 people
Software Development Team
1 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of CinRx Pharma
CinRx Pharma has successfully raised a total of $83M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $73 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by CinRx Pharma
Investment portfolio details for CinRx Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CinRx Pharma
Detailed financials for CinRx Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cinrx Pharma Comparisons
Peer comparison for CinRx Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CinRx Pharma
CinRx Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of CinRx Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cinrx Pharma
Complete news archive for CinRx Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CinRx Pharma
CinRx Pharma was founded in 2015 and raised its 1st funding round 9 years after it was founded.
CinRx Pharma is headquartered in Cincinnati, United States. It is registered at Cincinnati, Ohio, United States.
Jonathan Isaacsohn is the current CEO of CinRx Pharma.
CinRx Pharma is a funded company, having raised a total of $83M across 2 funding rounds to date.
CINRX Pharma is developing NMEs in multiple therapeutic areas. The company is planning to file the IND application for its lead candidate CIN-102 (Deuterated Domperidone, a dopamine 2-receptor antagonist) for the treatment of gastroparesis by the first half of 2018. Other candidates in their pipeline include CIN-103, a novel agent for IBS-D (Idiophathic Bowel Syndrome with Diarrhoea), CIN-105 for a cardiovascular indication and CIN-101, for a dermatology indication. The company has a unique partnership with Medpace, through which the CRO will offer clinical development resources through a preferred cost relationship and will also help in making early GoNo Go decisions.
CinRx Pharma's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.